Cargando…
YangXue QingNao Wan, a Compound Chinese Medicine, Attenuates Cerebrovascular Hyperpermeability and Neuron Injury in Spontaneously Hypertensive Rat: Effect and Mechanism
OBJECTIVE: The purpose of the study was to explore the effect of YangXue QingNao Wan (YXQNW), a compound Chinese medicine, on cerebrovascular hyperpermeability, neuronal injury, and related mechanisms in spontaneously hypertensive rat (SHR). METHODS: Fourteen-week-old male SHR were used, with Wistar...
Autores principales: | Jiao, Ying-Qian, Huang, Ping, Yan, Li, Sun, Kai, Pan, Chun-Shui, Li, Quan, Fan, Jing-Yu, Ma, Zhi-Zhong, Han, Jing-Yan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6779832/ https://www.ncbi.nlm.nih.gov/pubmed/31632292 http://dx.doi.org/10.3389/fphys.2019.01246 |
Ejemplares similares
-
Exploring the mechanism of YangXue QingNao Wan based on network pharmacology in the treatment of Alzheimer’s disease
por: Zhang, Yuying, et al.
Publicado: (2022) -
YangXue QingNao Wan and Silibinin Capsules, the Two Chinese Medicines, Attenuate Cognitive Impairment in Aged LDLR (+/-) Golden Syrian Hamsters Involving Protection of Blood Brain Barrier
por: Gu, You-Yu, et al.
Publicado: (2018) -
Therapeutic effect of Yang-Xue-Qing-Nao granules on sleep dysfunction in Parkinson’s disease
por: Pan, Weidong, et al.
Publicado: (2013) -
A meta‐analysis of the effectiveness of Yangxue Qingnao granules for the treatment of chronic cerebral circulation insufficiency
por: Jia, Yujuan, et al.
Publicado: (2020) -
Efficacy and safety of Yangxue Qingnao granules for the treatment of essential hypertension: A protocol for systematic review and meta-analysis
por: Liu, Yongcheng, et al.
Publicado: (2021)